We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
Cap. Flow
+$288M
Cap. Flow %
8.77%
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$42.5M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.3M
3
SEER icon
Seer Inc
SEER
+$20.8M
4
GKOS icon
Glaukos
GKOS
+$17.9M
5
COO icon
Cooper Companies
COO
+$17.1M

Top Sells

Rank Stock Value
1
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$60.7M
2
NTLA icon
Intellia Therapeutics
NTLA
+$26.2M
3
ORGO icon
Organogenesis Holdings
ORGO
+$19.9M
4
LLY icon
Eli Lilly
LLY
+$15.1M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Consumer Staples 0.8%
3 Technology 0.71%
4 Industrials 0.71%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KIDS icon
76
PUT
OrthoPediatrics
KIDS
$650M
$11.1M 0.34%
+169,600
New +$11M
XLRN
77
CALL
DELISTED
Acceleron Pharma
XLRN
$11.1M 0.34%
+64,400
New +$8.42M
CDXS icon
78
Codexis
CDXS
$172M
$11.1M 0.34%
476,170
-7,797
-2% -$185K
DHR icon
79
PUT
Danaher
DHR
$145B
$10.7M 0.32%
39,480
-64,409
-62% -$17.5M
AMGN icon
80
CALL
Amgen
AMGN
$225B
$10.6M 0.32%
+50,000
New +$11.5M
GILD icon
81
CALL
Gilead Sciences
GILD
$168B
$10.5M 0.32%
+150,000
New +$10.5M
OCDX
82
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$10.2M 0.31%
+550,000
New +$11.1M
PRVA icon
83
Privia Health
PRVA
$2.76B
$9.86M 0.3%
418,613
+72,569
+21% +$2.53M
ISEE
84
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$9.84M 0.3%
+605,800
New +$6.59M
SWAV
85
PUT
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$9.78M 0.3%
+47,500
New +$9.33M
ABMD
86
PUT
DELISTED
Abiomed Inc
ABMD
$9.77M 0.3%
+30,000
New +$10.2M
ATAI icon
87
PUT
AtaiBeckley Inc
ATAI
$2.68B
$9.64M 0.29%
+651,500
New +$10.6M
XLV icon
88
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$44.1B
$9.55M 0.29%
75,000
-225,000
-75% -$29.7M
CTKB icon
89
Cytek Biosciences
CTKB
$617M
$9.51M 0.29%
+444,368
New +$10.5M
ZBH icon
90
Zimmer Biomet
ZBH
$18.5B
$9.51M 0.29%
66,950
+15,450
+30% +$2.27M
NVRO
91
CALL
DELISTED
NEVRO CORP.
NVRO
$9.31M 0.28%
+80,000
New +$10.5M
TXG icon
92
10x Genomics
TXG
$7.5B
$9.27M 0.28%
63,661
-976
-2% -$168K
PSNL icon
93
Personalis
PSNL
$1.52B
$9.23M 0.28%
479,651
+4,643
+1% +$97.1K
AMN icon
94
AMN Healthcare
AMN
$1.27B
$9.18M 0.28%
+80,000
New +$8.48M
HAE icon
95
Haemonetics
HAE
$4.12B
$9.18M 0.28%
+130,000
New +$8.2M
STXS icon
96
Stereotaxis
STXS
$137M
$9.03M 0.27%
1,678,638
+226,292
+16% +$1.71M
FLGT icon
97
PUT
Fulgent Genetics
FLGT
$517M
$8.99M 0.27%
100,000
– –
OLK
98
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$8.8M 0.27%
362,746
+71,468
+25% +$2.25M
ADPT icon
99
Adaptive Biotechnologies
ADPT
$3.99B
$8.7M 0.26%
255,916
-47,116
-16% -$1.7M
DNA icon
100
Ginkgo Bioworks
DNA
$488M
$8.69M 0.26%
+18,750
New +$9.13M
2 3
4
5 6

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.

  • Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
  • Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
  • Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
  • Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
  • Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
  • Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
  • Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.